Taffic 90mg vs Ticagrelor Leeford 90mg: Same Molecule, Different Brands Compared

Introduction

Heart attacks and Acute Coronary Syndrome (ACS) remain among the leading causes of death and disability worldwide. Following a heart attack or coronary stent placement, preventing additional blood clots is a critical part of long-term treatment. This is why cardiologists often prescribe antiplatelet medicines such as Ticagrelor, usually in combination with low-dose aspirin as part of Dual Antiplatelet Therapy (DAPT).

Patients frequently compare different Ticagrelor brands, including Taffic 90mg and Ticagrelor Leeford 90mg, to understand whether there are meaningful differences in effectiveness, safety, or quality. While both products contain the same active ingredient, factors such as the manufacturer, packaging, availability, and pricing may differ.

In this guide, we compare Taffic 90mg vs Ticagrelor Leeford 90mg, explain how Ticagrelor works, discuss approved clinical uses, highlight important safety considerations, and clarify why patients should only use the brand and dose recommended by their healthcare provider.

What Is Ticagrelor?

Understanding Ticagrelor

Ticagrelor is a prescription antiplatelet medicine that belongs to a group of medicines called P2Y12 receptor inhibitors. It reduces the ability of platelets to stick together and form harmful blood clots inside the arteries.

Unlike blood thinners (anticoagulants), Ticagrelor specifically targets platelet activity. This makes it an important medicine for people who have experienced certain cardiovascular conditions where clot formation inside the arteries is a major concern.

How Ticagrelor Helps Prevent Blood Clots

When a blood vessel in the heart is damaged or a cholesterol plaque ruptures, platelets become activated and rapidly clump together to form a clot. While this process helps stop bleeding after injuries, it can also block blood flow inside the coronary arteries.

Ticagrelor blocks the P2Y12 receptor on platelets, reducing their ability to aggregate. As a result, it lowers the risk of new clot formation and helps reduce the chance of future cardiovascular events in appropriate patients.

Why Cardiologists Prescribe Ticagrelor

Cardiologists commonly prescribe Ticagrelor for patients with:

Acute Coronary Syndrome (ACS)

Patients diagnosed with unstable angina, NSTEMI, or STEMI often receive Ticagrelor as part of evidence-based treatment.

Heart Attack Management

Following a heart attack, Ticagrelor helps reduce the risk of another cardiovascular event when used according to current clinical guidelines.

After Angioplasty (PCI)

Patients who undergo Percutaneous Coronary Intervention (PCI) with coronary stent placement are commonly prescribed Ticagrelor with aspirin to reduce the risk of stent thrombosis.

Prevention of Recurrent Cardiovascular Events

In selected high-risk patients, Ticagrelor may be continued for a period recommended by the treating cardiologist to help reduce recurrent cardiovascular events.

Product Overview

Taffic 90mg

Taffic 90mg is a prescription medicine containing Ticagrelor 90mg.

Active Ingredient: Ticagrelor

Strength: 90mg

Drug Class: P2Y12 Receptor Inhibitor

Dosage Form: Oral Tablet

Prescription Medicine: Yes

Patients should use Taffic 90mg only under the supervision of a qualified healthcare professional and exactly as prescribed.

Ticagrelor Leeford 90mg

Ticagrelor Leeford 90mg also contains Ticagrelor 90mg as its active ingredient.

Active Ingredient: Ticagrelor

Strength: 90mg

Drug Class: P2Y12 Receptor Inhibitor

Dosage Form: Oral Tablet

Manufacturer: Leeford

Prescription Medicine: Yes

Like all Ticagrelor products, it should only be taken after medical evaluation and prescription.

Taffic 90mg vs Ticagrelor Leeford 90mg – Quick Comparison

Same Active Ingredient, Different Brands

One of the most common questions patients ask is whether two different brands containing the same medicine are identical. Understanding the relationship between the active ingredient and the brand name helps answer this question.

What Does "Same Molecule" Mean?

Both Taffic 90mg and Ticagrelor Leeford 90mg contain the same active pharmaceutical ingredient (API): Ticagrelor 90mg. The active ingredient is the component responsible for producing the medicine's therapeutic effect by reducing platelet aggregation.

When used according to approved prescribing information, both products are intended to deliver the same active molecule to the body.

Why Brand Names Matter

Although the active ingredient is the same, different pharmaceutical companies manufacture their own branded versions of Ticagrelor. These products may differ in:

• Brand name
• Manufacturer
• Tablet appearance
• Packaging design
• Excipients (inactive ingredients)
• Availability
• Pricing

These differences generally do not change the intended therapeutic action of the active ingredient when the medicine has been approved by the relevant regulatory authority.

Can They Be Used Interchangeably?

Patients should never switch from one brand to another on their own, even if both contain Ticagrelor 90mg.

Your cardiologist may recommend continuing the same brand for consistency or prescribe another approved brand when appropriate. Any change should be made only after consulting your healthcare provider or pharmacist.

How Ticagrelor Works

Platelet Inhibition

Platelets are tiny blood cells that help stop bleeding by forming clots. After a heart attack or coronary intervention, excessive platelet activation can lead to dangerous clot formation inside the arteries.

Ticagrelor blocks platelet activation by inhibiting the P2Y12 receptor, reducing the likelihood of harmful clot formation.

Preventing Blood Clot Formation

By preventing platelets from sticking together, Ticagrelor helps reduce the risk of:

• Heart attack
• Stent thrombosis
• Stroke in selected patients
• Other cardiovascular complications associated with platelet-mediated clot formation

It does not dissolve existing blood clots but helps prevent new clots from forming.

Reducing the Risk of Heart Attack and Stroke

When used together with low-dose aspirin (if prescribed), Ticagrelor forms part of Dual Antiplatelet Therapy (DAPT), which is a cornerstone of modern treatment following Acute Coronary Syndrome and coronary stent placement.

Approved Uses of Ticagrelor

Ticagrelor is approved for several cardiovascular indications in appropriate patients.

Acute Coronary Syndrome (ACS)

It is widely prescribed following unstable angina, NSTEMI, and STEMI to reduce the risk of recurrent cardiovascular events.

After Percutaneous Coronary Intervention (PCI)

Patients undergoing coronary angioplasty with stent placement commonly receive Ticagrelor as part of Dual Antiplatelet Therapy to help prevent stent thrombosis.

Prevention of Cardiovascular Events

Selected patients at increased cardiovascular risk may continue Ticagrelor for a duration determined by their cardiologist based on current clinical guidelines and individual risk factors.

Use with Aspirin (When Prescribed)

Ticagrelor is frequently prescribed together with low-dose aspirin, unless there is a specific medical reason not to use this combination. Patients should follow the exact treatment plan recommended by their healthcare provider.

Key Differences Between Taffic 90mg and Ticagrelor Leeford 90mg

Although both products contain Ticagrelor 90mg, there are a few practical differences that patients may notice.

Active Ingredient and Strength

Both medicines contain the same active ingredient (Ticagrelor) in the same 90mg strength. There is no difference in the prescribed dose based solely on the brand name.

Brand and Manufacturer

The primary distinction is the manufacturer. Taffic and Ticagrelor Leeford are marketed under different brand names by different pharmaceutical companies, which may result in variations in packaging, tablet appearance, and inactive ingredients.

Packaging

Each manufacturer designs its own packaging, blister packs, labeling, and branding. Patients should always verify the medicine name and strength before taking any tablet.

Availability and Pricing

Availability may vary depending on the pharmacy, region, and supplier. Prices can also differ between brands. However, cost should never be the only factor when selecting a prescription medicine.

Safety Considerations Before Taking Ticagrelor

Whether you are prescribed Taffic 90mg or Ticagrelor Leeford 90mg, it is important to understand that both medicines contain the same active ingredient and therefore have similar safety considerations. Before starting treatment, your healthcare provider will evaluate your medical history, current medications, and overall risk of bleeding.

Bleeding Risk

The most significant risk associated with Ticagrelor is bleeding. Since the medicine reduces the ability of platelets to form blood clots, even minor injuries may bleed for longer than usual.

Seek immediate medical attention if you notice:

• Unusual or prolonged bleeding
• Blood in the urine
• Black or tarry stools
• Vomiting blood or material that looks like coffee grounds
• Severe nosebleeds that do not stop
• Persistent gum bleeding
• Unexplained bruising
• Severe headache after a fall or injury

Patients with a history of stomach ulcers, previous bleeding episodes, or bleeding disorders should inform their doctor before starting Ticagrelor.

Drug Interactions

Ticagrelor may interact with several prescription and over-the-counter medicines. These interactions can increase the risk of bleeding or affect how the medicine works.

Examples include:

• Anticoagulants (blood thinners)
• Aspirin in doses higher than recommended
• Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen
• Certain antifungal medicines
• Some antibiotics
• Medicines used to treat HIV
• Certain cholesterol-lowering medicines
• Herbal supplements such as ginkgo biloba

Always tell your healthcare provider about every medicine or supplement you are taking before starting Ticagrelor.

Surgery and Dental Procedures

If you are scheduled for surgery, dental treatment, or any invasive procedure, inform your surgeon or dentist that you are taking Ticagrelor.

Depending on the procedure and your cardiovascular condition, your doctor may provide specific instructions regarding your medication. Never stop Ticagrelor on your own, as doing so may increase the risk of heart attack or stent thrombosis.

Liver Disease Considerations

Ticagrelor is processed by the liver. Patients with severe liver disease may not be suitable candidates for this medicine. Your doctor may recommend additional evaluation if you have a history of liver problems.

Importance of Taking the Medicine Exactly as Prescribed

Ticagrelor works best when taken consistently according to the prescribed schedule. Missing doses or stopping treatment without medical advice can significantly increase the risk of blood clot formation.

Take the medicine:

• At the same time every day
• Exactly as prescribed
• Without skipping doses
• Along with aspirin if recommended by your cardiologist

If you accidentally miss a dose, follow the instructions provided by your healthcare provider or the product information leaflet.

Possible Side Effects of Ticagrelor

Like all prescription medicines, Ticagrelor may cause side effects. Most patients tolerate the medicine well, but some may experience mild or more serious reactions.

Common Side Effects

Not everyone experiences these side effects, and many are mild and manageable. However, persistent or worsening symptoms should be discussed with your healthcare provider.

Serious Side Effects

Although uncommon, serious complications require immediate medical attention.

These include:

• Severe or uncontrolled bleeding
• Allergic reactions such as swelling of the face, lips, tongue, or throat
• Difficulty breathing
• Fainting
• Signs of internal bleeding
• Sudden weakness or difficulty speaking, which could indicate a stroke

If any of these symptoms occur, seek emergency medical care immediately.

When to Seek Immediate Medical Attention

Contact your doctor or visit the nearest emergency department if you experience:

• Chest pain that worsens
• Heavy or uncontrollable bleeding
• Vomiting blood
• Black stools
• Severe dizziness or fainting
• Sudden shortness of breath
• Loss of consciousness
• Signs of stroke such as facial drooping or weakness on one side of the body

Prompt medical evaluation is essential to reduce the risk of serious complications.

How Doctors Choose the Right Ticagrelor Brand

Choosing between Taffic 90mg and Ticagrelor Leeford 90mg is generally not about which medicine is "better." Since both contain Ticagrelor 90mg, the decision usually depends on practical and patient-specific considerations.

Diagnosis

Doctors first consider the patient's diagnosis, such as:

• Acute Coronary Syndrome (ACS)
• Heart attack (Myocardial Infarction)
• Coronary stent placement (PCI)
• Long-term prevention of cardiovascular events

The diagnosis determines whether Ticagrelor is appropriate and how long treatment should continue.

Treatment Stage

The timing of treatment is another important consideration.

Patients may require Ticagrelor:

• Immediately after a heart attack
• Following coronary angioplasty
• During the maintenance phase of Dual Antiplatelet Therapy

The treatment plan may evolve over time depending on the patient's recovery and overall cardiovascular risk.

Patient Age

Older adults may have a higher risk of bleeding. Doctors carefully balance the benefits of preventing blood clots with the potential risks associated with antiplatelet therapy.

Bleeding Risk

Before prescribing Ticagrelor, healthcare providers assess factors such as:

• Previous bleeding episodes
• Stomach ulcers
• Recent surgery
• Bleeding disorders
• Other medicines that increase bleeding risk

This evaluation helps determine whether Ticagrelor is appropriate for the individual patient.

Other Medications

Many patients with heart disease take multiple medicines, including:

• Blood pressure medications
• Cholesterol-lowering medicines
• Diabetes medications
• Aspirin
• Anticoagulants

Doctors review all medications to minimize the risk of drug interactions and ensure safe treatment.

Current Cardiology Guidelines

Modern cardiology practice follows evidence-based clinical guidelines developed from large international studies. These recommendations help healthcare providers select the most appropriate antiplatelet therapy based on each patient's condition and risk profile.

Why Choose Shabbir Medical Hall for Cardiac Medicines?

Trusted Pharmacy Since 1920

For more than a century, Shabbir Medical Hall has been committed to supplying genuine prescription medicines while supporting patients with dependable pharmacy services across India.

Why Patients Trust Us

• Genuine prescription medicines
• Comprehensive range of cardiology medicines
• Competitive pricing
• Prescription verification
• Secure packaging
• Fast order processing
• Nationwide delivery
• Dedicated customer support

Looking for Genuine Ticagrelor Tablets?

Shabbir Medical Hall provides authentic prescription cardiac medicines with prescription verification, secure packaging, reliable nationwide delivery, and responsive customer support. A valid prescription from a registered healthcare professional is required.

Conclusion

Both Taffic 90mg and Ticagrelor Leeford 90mg contain the same active ingredient, Ticagrelor 90mg, and are prescribed to help reduce the risk of blood clot formation in patients with Acute Coronary Syndrome, following coronary stent placement, and in other approved cardiovascular conditions. The primary differences relate to the brand, manufacturer, packaging, availability, and pricing, rather than the active medicine itself.

The most appropriate choice should always be based on your cardiologist's recommendation, current clinical guidelines, and your individual treatment plan. Never change your Ticagrelor brand or stop taking your medication without professional medical advice. For genuine prescription cardiac medicines, secure packaging, and reliable nationwide delivery, choose a trusted licensed pharmacy such as Shabbir Medical Hall.

Frequently Asked Questions (FAQ)

1. Is Taffic 90mg the same as Ticagrelor Leeford 90mg?

Yes. Both medicines contain Ticagrelor 90mg as the active ingredient. They are different brands manufactured by different pharmaceutical companies, but they contain the same molecule and strength.

2. Can I replace Ticagrelor Leeford 90mg with Taffic 90mg?

You should not switch brands on your own. Although both contain Ticagrelor 90mg, any change should be made only after consulting your treating physician or pharmacist.

3. Why are different brands of Ticagrelor available?

Different pharmaceutical manufacturers produce approved Ticagrelor tablets under different brand names. While the active ingredient remains the same, packaging, appearance, availability, and pricing may vary.

4. What are the common side effects of Ticagrelor?

Common side effects include bleeding, easy bruising, shortness of breath, nosebleeds, headache, and dizziness. If you experience severe bleeding or unusual symptoms, seek medical attention immediately.

5. Do both brands require a prescription?

Yes. Both Taffic 90mg and Ticagrelor Leeford 90mg are prescription-only medicines and should be used only under the supervision of a qualified healthcare professional.

6. Where can I buy genuine Ticagrelor tablets in India?

You can purchase genuine Ticagrelor tablets from licensed pharmacies such as Shabbir Medical Hall after verification of a valid prescription from a registered healthcare professional.